Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer
Clinical trial NCT00317772 · COMPLETED
Trial details
- NCT number
- NCT00317772
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-02
- Primary completion
- 2020-11-04
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.